Figures computed from official regulatory filings — .
Ownershipinsiders 1.46% · institutions 8.01% · short 2.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Valion Bio, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
19 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Wolf Lisa G | Other | $4.2 | SEC |
| Zikria Dean | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wolf Lisa G | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Wolf Lisa G | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wolf Lisa G | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wolf Lisa G | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Handley Michael K | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Handley Michael K | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Lackey Melinda | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bolton Sheryle | Buy | $10.4K | conv 83First in 12mo | SEC |
| Valauri Christina Rizopoulos | Buy | $18K | conv 77First in 12mo | SEC |
| Wolf Lisa G | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wolf Lisa G | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Handley Michael K | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Handley Michael K | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ernst Jennifer | Other | $9.8K | SEC |
| Ernst Jennifer | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wolf Lisa G | Other | $564.7 | SEC |
| Ernst Jennifer | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Wolf Lisa G | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Wolf Lisa G | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ernst Jennifer | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Handley Michael K | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wolf Lisa G | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ernst Jennifer | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |